Proprotein convertase subtisilin/kexin 9 (PCSK9) levels decline with HCV therapy in people with HIV/HCV and correlate with inflammation

By sjmartinez • October 4, 2023

Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Merz CNB, Jordan WC, Daar ES, Bhattacharya D, Chew KW. Proprotein convertase subtisilin/kexin 9 (PCSK9) levels decline with HCV therapy in people with HIV/HCV and correlate with inflammation. AIDS. 2023 Oct 2. doi: 10.1097/QAD.0000000000003739. Epub ahead of print. PMID: 37788081.

Tags: Cardiology/Epi, CARE Unit, Harbor UCLA, Infectious Diseases, Publications, Veterans Administration

Related Posts

Air Pollution Triggers Metabolomic Signature of Mitochondrial Dysfunction in Mice and Humans: Implications for Cardiovascular Disease Development

Lin Y, Qiu X, Gupta R, Ramanathan G, Lu X, Yin F, Fiehn O, Zhang JJ, Kaufman JD, Zhu Y, Rosenfeld M, Araujo JA. Air[...]

Lamin B1 Coordinates the Assembly of the Nuclear Lamina

Kim JR, Kim PH, Tu Y, Carroll J, Koerner JP, Young SG, Fong LG. Lamin B1 Coordinates the Assembly of the Nuclear Lamina. J Cell[...]

Regulators of Mineralization and Long-Term Progression of Aortic Valve and Mitral Annular Calcification: MESA

Bortnick AE, Naveed M, Fu X, Shea K, Kestenbaum B, de Boer I, Ix JH, Kim R, Hamerton E, Kankaria R, Tracy RP, Tsai M,[...]